Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
4D Molecular Therapeutics | FDMT | Dec 24, 2024 | 5.81 | -1.19 |
51Talk Online Education Group ADR | COE | Dec 24, 2024 | 17.00 | -2.58 |
5E Advanced Materials | FEAM | Dec 24, 2024 | 0.44 | -1.38 |
60 Degrees Pharmaceuticals | SXTP | Dec 24, 2024 | 1.32 | +13.79 |
7-10 Yr Trsy Bear 3X Direxion | TYO | Dec 24, 2024 | 14.95 | +0.11 |
7-10 Yr Trsy Bull 3X Direxion | TYD | Dec 24, 2024 | 23.38 | +0.04 |
7-10 Yr Trsy Ishares | IEF | Dec 24, 2024 | 92.25 | +0.05 |
89bio | ETNB | Dec 24, 2024 | 7.94 | -0.63 |
8x8 | EGHT | Dec 24, 2024 | 2.68 | -0.74 |
908 Devices | MASS | Dec 24, 2024 | 1.92 | +1.05 |
9F ADR | JFU | Dec 24, 2024 | 1.51 | +0.67 |
A SPAC II Acquisition | ASCB | Dec 24, 2024 | 11.19 | 0.00 |
A-Mark Precious Metals | AMRK | Dec 24, 2024 | 25.95 | +2.37 |
a.k.a Brands | AKA | Dec 24, 2024 | 19.82 | -7.12 |
A.O Smith | AOS | Dec 24, 2024 | 68.89 | +0.48 |
A10 Networks | ATEN | Dec 24, 2024 | 18.61 | +0.54 |
A2Z Cust2Mate Solutions | AZ | Dec 24, 2024 | 7.09 | -0.84 |
AA Mission Acquisition | AAM | Dec 24, 2024 | 10.10 | +0.09 |
AAA - A Rated Corporate Bond Ishares | QLTA | Dec 24, 2024 | 46.84 | +0.28 |
Aadi Bioscience | AADI | Dec 24, 2024 | 3.00 | +4.90 |
AAON | AAON | Dec 24, 2024 | 123.44 | +0.19 |
AAR | AIR | Dec 24, 2024 | 60.93 | +1.79 |
Abacus Life | ABL | Dec 24, 2024 | 7.54 | -3.33 |
Abbott Laboratories | ABT | Dec 24, 2024 | 114.76 | +0.39 |
AbbVie | ABBV | Dec 24, 2024 | 180.00 | +0.90 |
AbCellera Biologics | ABCL | Dec 24, 2024 | 2.95 | +1.03 |
Abeona Therapeutics | ABEO | Dec 24, 2024 | 5.68 | -0.18 |
Abercrombie & Fitch | ANF | Dec 24, 2024 | 152.07 | -0.58 |
Aberdeen Asia-Pacificome Fund | FAX | Dec 24, 2024 | 15.40 | +0.91 |
Aberdeen Australia Equity Fund | IAF | Dec 24, 2024 | 4.29 | +0.47 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.